Log in
Enquire now
‌

Genkyotex

Drug development platform targeting NOX enzymes to prevent oxygen radical production.

OverviewStructured DataIssuesContributors

Contents

Is a
Organization
Organization
Company
Company

Company attributes

Industry
Biology
Biology
Health technology
Health technology
Biotechnology
Biotechnology
Consumer biotechnology
Consumer biotechnology
Biomedical engineering
Biomedical engineering
Technology
Technology
‌
Deep Tech
...
Location
Auvergne-Rhône-Alpes
Auvergne-Rhône-Alpes
B2X
B2B
B2B
Number of Employees (Ranges)
11 – 50
Investors
Edmond de Rothschild Venture Capital
Edmond de Rothschild Venture Capital
MP Healthcare Venture Management
MP Healthcare Venture Management
BioMedPartners
BioMedPartners
‌
Societe Generale Asset Management
Vesalius Biocapital Partners
Vesalius Biocapital Partners
Eclosion SA
Eclosion SA
Founded Date
2006
Total Funding Amount (USD)
51,770,000
Latest Funding Round Date
May 24, 2011
July 9, 2012
Also Known As
GenKyoTex
Genkyotex S.A
Latest Funding Type
Series C
Series C
Country
France
France
Switzerland
Switzerland
Headquarters
Geneva
Geneva

Other attributes

Latest Funding Round Amount (USD)
26,000,000
20,400,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Genkyotex

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.